Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.

Sahera Dirajlal-FargoAbdus SattarManjusha KulkarniNicholas FunderburgGrace A McComsey

Published in: HIV clinical trials (2017)

HIV-infected participants showed increased systemic inflammatory and monocyte activation markers. Soluble CD163 and sTWEAK levels were associated with carotid intima-media thickness.

Keyphrases

hiv infected
antiretroviral therapy
human immunodeficiency virus
cardiovascular disease
oxidative stress
endothelial cells
cardiovascular risk factors
type diabetes
nk cells
metabolic syndrome
newly diagnosed
drug induced